NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Joway Health Industries Group does not have significant operations. Previously, it was engaged in the manufacture and sale of tourmaline-related healthcare products. The company is based in Las Vegas, Nevada.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | -$222,607.00 | -$121,788.00 | -$74,708.00 | -$4.2M | -$3.0M | -$4.7M | -$2.6M |
| Net income | -$2.3M | -$121,788.00 | -$74,708.00 | -$4.3M | -$3.7M | -$5.1M | -$3.1M |
| Diluted EPS | — | -$0.01 | $0.00 | -$0.18 | -$0.02 | -$0.42 | -$0.23 |
| Operating cash flow | -$564,761.00 | -$70,079.00 | — | -$147,574.00 | -$868,428.00 | -$2.5M | -$818,603.00 |
| Free cash flow | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '25 | Q '25 | Q2 '25 | Q3 '25 | Q4 '26 | Q '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$943,460.00 | -$2.2M | -$598,133.00 | -$563,138.00 | -$701,469.00 | -$669,987.00 | -$689,083.00 | -$1.3M |
| Net income | -$1.0M | -$2.4M | -$704,504.00 | -$682,888.00 | -$777,964.00 | -$789,035.00 | -$825,077.00 | -$1.5M |
| Diluted EPS | $0.00 | -$0.01 | -$0.41 | -$0.05 | $0.00 | $0.00 | -$0.18 | -$0.11 |
| Operating cash flow | -$820,838.00 | -$472,525.00 | -$431,709.00 | -$225,967.00 | -$100,156.00 | -$133,428.00 | -$359,052.00 | -$855,058.00 |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.